Therapeutic composition for intraperitoneal administration
AssigneeCapnomed GmbH
InventorsAlexander HETZEL, Janek KIBAT, Ranjita SAHOO, Mona KIBAT
Life of this patent
Estimating the term…
Loading patent…
AssigneeCapnomed GmbH
InventorsAlexander HETZEL, Janek KIBAT, Ranjita SAHOO, Mona KIBAT
Estimating the term…
The present invention refers to a set for the production of a ready-to-use chemo-therapeutic composition for intraperitoneal administration as an aerosol, wherein the set comprises an aqueous concentrate containing at least cisplatin in a first predetermined concentration and doxorubicin in a second predetermined concentration with a predetermined ratio of the first and the second concentration and having a pH value in the range from 3.0 to 7.0. The set further comprises a physiological aqueous carrier solution, which is for optional dilution of the concentrate depending on target concentrations of cisplatin and doxorubicin in the chemo-therapeutic composition to be applied. Further, the invention refers to a method for providing of a ready-for-use chemotherapeutic composition for intraperitoneal administration as an aerosol by using of a set, to a chemotherapeutic composition for intraperitoneal administration as an aerosol, and a use of the chemotherapeutic composition.
A set for the production of a ready-to-use chemotherapeutic composition for intraperitoneal administration as aerosol comprising an aqueous concentrate comprising at least cisplatin in a first predetermined concentration and doxorubicin in a second predetermined concentration with a predetermined ratio of the first and the second concentrations and a pH value ranging from 3.0 to 7.0.
A method for providing a ready-for-use chemotherapeutic composition for intraperitoneal administration as an aerosol comprising:
13-15. (canceled)
Dependencies are inferred from the claim text.